Compile Data Set for Download or QSAR
Report error Found 61 Enz. Inhib. hit(s) with all data for entry = 11003
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM585012(US11529321, Compound 40)
Affinity DataIC50: 9.00E+3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM585023(US11529321, Compound 51)
Affinity DataIC50: 9.00E+3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM585021(US11529321, Compound 49)
Affinity DataIC50: 9.00E+3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM585020(US11529321, Compound 48)
Affinity DataIC50: 9.00E+3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM585019(US11529321, Compound 47)
Affinity DataIC50: 9.00E+3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM585017(US11529321, Compound 45)
Affinity DataIC50: 9.00E+3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM585016(US11529321, Compound 44)
Affinity DataIC50: 9.00E+3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM585015(US11529321, Compound 43)
Affinity DataIC50: 9.00E+3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM585014(US11529321, Compound 42)
Affinity DataIC50: 9.00E+3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM585024(US11529321, Compound 52)
Affinity DataIC50: 9.00E+3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM55432(MLS000558830 | cid_4637001 | 4-[2-[[4-(furan-2-yl)...)
Affinity DataIC50: 9.00E+3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM585010(US11529321, Compound 38)
Affinity DataIC50: 9.00E+3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM585009(US11529321, Compound 37)
Affinity DataIC50: 9.00E+3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM585007(US11529321, Compound 35)
Affinity DataIC50: 9.00E+3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM56364(SMR000129520 | N-(3-chlorophenyl)-4-[2-[(2,6-dioxo...)
Affinity DataIC50: 9.00E+3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM585004(US11529321, Compound 32)
Affinity DataIC50: 9.00E+3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM585005(US11529321, Compound 33)
Affinity DataIC50: 9.00E+3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM585026(US11529321, Compound 54)
Affinity DataIC50: 9.00E+3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM585029(US11529321, Compound 57)
Affinity DataIC50: 9.00E+3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM584986(US11529321, Compound 14)
Affinity DataIC50: 9.00E+3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM584985(US11529321, Compound 13)
Affinity DataIC50: 9.00E+3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM76261(SMR000019406 | MLS000042979 | 5-(2-furanyl)-2-[[2-...)
Affinity DataIC50: 9.00E+3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM585031(US11529321, Compound 59)
Affinity DataIC50: 9.00E+3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM584982(US11529321, Compound 10)
Affinity DataIC50: 9.00E+3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM584981(US11529321, Compound 9)
Affinity DataIC50: 9.00E+3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM585032(US11529321, Compound 60)
Affinity DataIC50: 9.00E+3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM584979(US11529321, Compound 7)
Affinity DataIC50: 9.00E+3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM584978(US11529321, Compound 6)
Affinity DataIC50: 9.00E+3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM584977(US11529321, Compound 5)
Affinity DataIC50: 9.00E+3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM584976(US11529321, Compound 4)
Affinity DataIC50: 9.00E+3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM584975(US11529321, Compound 3)
Affinity DataIC50: 9.00E+3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM584973(US11529321, Compound 1 | Synthesis of Compound 2-(...)
Affinity DataIC50: 9.00E+3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM585033(US11529321, Compound 61)
Affinity DataIC50: 5.75E+4nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM584974(US11529321, Compound 2)
Affinity DataIC50: 5.75E+4nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM584983(US11529321, Compound 11 | Synthesis of Compound 5-...)
Affinity DataIC50: 5.75E+4nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM584984(US11529321, Compound 12)
Affinity DataIC50: 5.75E+4nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM584987(US11529321, Compound 15)
Affinity DataIC50: 5.75E+4nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM584988(US11529321, Compound 16)
Affinity DataIC50: 5.75E+4nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM584992(US11529321, Compound 20)
Affinity DataIC50: 5.50E+5nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM56282(SMR000103130 | 5,5-dimethyl-2-[[2-(4-propanoylpipe...)
Affinity DataIC50: 5.50E+5nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM585028(US11529321, Compound 56)
Affinity DataIC50: 5.50E+5nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM585027(US11529321, Compound 55)
Affinity DataIC50: 5.50E+5nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM585025(US11529321, Compound 53)
Affinity DataIC50: 5.50E+5nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM40959(MLS000084255 | SMR000048084 | cid_666690 | 5,5-dim...)
Affinity DataIC50: 5.50E+5nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM584990(US11529321, Compound 18)
Affinity DataIC50: 5.50E+5nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM585022(US11529321, Compound 50)
Affinity DataIC50: 5.50E+5nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM584991(US11529321, Compound 19)
Affinity DataIC50: 5.50E+5nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM50085(2-[[[6-[[4,4-dimethyl-2,6-bis(oxidanylidene)cycloh...)
Affinity DataIC50: 5.50E+5nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM584993(US11529321, Compound 21)
Affinity DataIC50: 5.50E+5nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandPNGBDBM585018(US11529321, Compound 46)
Affinity DataIC50: 5.50E+5nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was expressed and purified, and a preliminary screening and verification platform w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
Go to US Patent

Displayed 1 to 50 (of 61 total ) | Next | Last >>
Jump to: